US appeals court affirms hold on pedigree requirements
This article was originally published in Scrip
Executive Summary
A US federal appeals court has affirmed a preliminary injunction blocking implementation of federal drug pedigree requirements. The injunction was granted in late 2006 at the request of secondary wholesalers, who challenged theFDA's decision to begin enforcing pedigree requirements for wholesalers who are not "authorised distributors". The provisions, which are aimed at stemming counterfeiting, would have required non-authorised distributors to provide written documentation of the chain of custody of products. The secondary wholesalers asserted they could not comply because authorised distributors were not required to turn over the necessary documentation to them. The appeals court agreed with the trial judge's ruling that the plaintiffs had demonstrated a likelihood of success on the merits of their claim that the FDA's actions were arbitrary and capricious.
You may also be interested in...
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
US FDA Drugs Center Launches Clinical Trial Innovation Hub With Demonstration Projects
CDER’s Center for Clinical Trial Innovation (C3TI) will support innovative clinical trial approaches designed to improve the quality and efficiency of drug development and regulatory decision-making. The initiative includes demonstration projects on Bayesian analyses, selective safety data collection and point-of-care trials.
Preterm Birth Prevention Studies Need To Look Beyond Makena Endpoints, Experts Say
Gestational age and a binary, neonatal composite endpoint are insufficient to assess outcomes that are important to babies and families, clinicians and researchers say, suggesting development of continuous variables or scales with weighted components and a comparison of outcomes among newborns in gestational age ‘buckets.’